Emmanuelle Lee Sells 3,405 Shares of Mirion Technologies, Inc. (NYSE:MIR) Stock

Mirion Technologies, Inc. (NYSE:MIR) insider Emmanuelle Lee sold 3,405 shares of the business’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $14.27, for a total value of $48,589.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Emmanuelle Lee also recently made the following trade(s):

• On Tuesday, September 24th, Emmanuelle Lee sold 5,000 shares of Mirion Technologies stock. The shares were sold at an average price of $10.60, for a total value of $53,000.00.

Mirion Technologies Stock Performance

Shares of Mirion Technologies stock opened at $15.00 on Wednesday. The company has a market cap of $3.48 billion, a PE ratio of -44.12 and a beta of 0.73. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. Mirion Technologies, Inc. has a 52 week low of $7.97 and a 52 week high of $15.17. The business has a 50 day moving average price of $11.98 and a 200-day moving average price of $11.08.

Mirion Technologies (NYSE:MIR) last released its quarterly earnings results on Tuesday, October 29th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). The company had revenue of $206.80 million during the quarter, compared to analysts’ expectations of $203.67 million. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. The company’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.03 earnings per share. Equities analysts anticipate that Mirion Technologies, Inc. will post 0.36 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in MIR. Essex Investment Management Co. LLC increased its stake in Mirion Technologies by 0.3% in the 3rd quarter. Essex Investment Management Co. LLC now owns 351,478 shares of the company’s stock valued at $3,891,000 after buying an additional 980 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of Mirion Technologies by 2.2% in the second quarter. Arizona State Retirement System now owns 48,968 shares of the company’s stock valued at $526,000 after acquiring an additional 1,045 shares in the last quarter. Rhumbline Advisers increased its position in shares of Mirion Technologies by 0.4% during the second quarter. Rhumbline Advisers now owns 325,569 shares of the company’s stock valued at $3,497,000 after acquiring an additional 1,340 shares during the last quarter. Oppenheimer & Co. Inc. lifted its holdings in Mirion Technologies by 4.7% during the third quarter. Oppenheimer & Co. Inc. now owns 58,260 shares of the company’s stock worth $645,000 after acquiring an additional 2,595 shares during the period. Finally, ProShare Advisors LLC boosted its position in Mirion Technologies by 8.5% in the first quarter. ProShare Advisors LLC now owns 36,017 shares of the company’s stock worth $410,000 after purchasing an additional 2,833 shares during the last quarter. 78.51% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on MIR shares. Citigroup increased their target price on Mirion Technologies from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Thursday, October 31st. B. Riley initiated coverage on shares of Mirion Technologies in a report on Thursday, September 26th. They set a “buy” rating and a $14.00 price objective on the stock. Finally, The Goldman Sachs Group lifted their price objective on shares of Mirion Technologies from $13.00 to $16.00 and gave the company a “buy” rating in a report on Thursday, October 31st.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.